Trial Profile

Metabolic impact of oral contraceptives with or without metformin in obese adolescents with polycystic ovary syndrome (PCOS)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Metformin (Primary) ; Drospirenone/ethinylestradiol; Ethinylestradiol/desogestrel; Oral contraceptives
Indications Polycystic ovary syndrome
Focus Pharmacodynamics

Most Recent Events

15 May 2015 Biomarkers information updated
12 Jul 2011 Actual initiation date (Jan 2006) added as reported by ClinicalTrials.gov.
11 Oct 2006 New trial record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com